IL6 and obesity disorder: In summary, the present study reveals a remarkable overactivation of non-canonical WNT5A/PCP signaling in visceral fat under obesity conditions, which contributes to the higher IL-6 production and systemic inflammation typically associated with visceral adiposity, in particular in individuals with diabetes.